This account is now @BNTBriefing, covering business, markets, energy, pharma, biotech, medical devices, geopolitics and industry analysis from https://t.co/dT0rwPvt3u and https://t.co/GvRNwmnAxz.
Follow for #executivenews, #marketcatalysts and #sectorintelligence.
@JohnsonJohnson has a new dual-energy ablation platform, but will hospitals adopt it? https://t.co/mQ1H6arBgz Find out how Johnson & Johnson ’s dual-energy ablation system could reshape cardiac arrhythmia procedures.#JohnsonAndJohnson #CardiacAblation #PulsedFieldAblation #AtrialFibrillation #MedTech #Electrophysiology #JNJ
@InSilicoMeds’s AI-originated IPF drug enters Phase 3, but the hardest test begins now https://t.co/RDiW5NFJNa Find out how Insilico Medicine Medicine’s AI-originated rentosertib is entering Phase 3 testing for idiopathic pulmonary fibrosis.#InsilicoMedicine#Rentosertib #IdiopathicPulmonaryFibrosis #AIDrugDiscovery #Biotechnology #ClinicalTrials #TNIK
@Pharvaris has an FDA review date for deucrictibant, but can it stand out? https://t.co/rIgZet3Lcx Find out how Pharvaris ’ deucrictibant could reshape oral treatment options for hereditary angioedema attacks.#Pharvaris#Deucrictibant#HereditaryAngioedema#RareDisease #Biotechnology #DrugDevelopment #FDAReview
Can @CoRegen’s CRG-150 turn regulatory T cells into a solid tumour weapon? https://t.co/hDAkUn1iiw Find out how CoRegen Inc. is advancing CRG-150 into human trials for metastatic breast cancer, prostate cancer and solid tumours.#CoRegen#CRG150#CellTherapy#CancerImmunotherapy #BreastCancer #ProstateCancer #Biotechnology